home All News open_in_new Full Article

New cancer treatment could 'change the world' for newly diagnosed head and neck cancer patients by adding several years to their life

During a major phase III trial, pembrolizumab combined with standard treatment kept cancer at bay for an average of 60 months - five years - compared to the typical 30 months.


today 9 h. ago attach_file Science

attach_file Science
attach_file Economics
attach_file Events
attach_file Politics
attach_file Science
attach_file Events
attach_file Events
attach_file Society
attach_file Events
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Society
attach_file Politics


ID: 1723116493
Add Watch Country

arrow_drop_down